OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes
Jawaher Alharthi, Ali Bayoumi, Khaled Thabet, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 31
Jawaher Alharthi, Ali Bayoumi, Khaled Thabet, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Therapeutic opportunities for the treatment of NASH with genetically validated targets
Daniel Lindén, Stefano Romeo
Journal of Hepatology (2023) Vol. 79, Iss. 4, pp. 1056-1064
Closed Access | Times Cited: 46
Daniel Lindén, Stefano Romeo
Journal of Hepatology (2023) Vol. 79, Iss. 4, pp. 1056-1064
Closed Access | Times Cited: 46
MAFLD as part of systemic metabolic dysregulation
Jing Zhao, Lu Liu, Yingying Cao, et al.
Hepatology International (2024) Vol. 18, Iss. S2, pp. 834-847
Closed Access | Times Cited: 14
Jing Zhao, Lu Liu, Yingying Cao, et al.
Hepatology International (2024) Vol. 18, Iss. S2, pp. 834-847
Closed Access | Times Cited: 14
Metabolic dysfunction: The silenced connection with fatty liver disease
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, et al.
Annals of Hepatology (2023) Vol. 28, Iss. 6, pp. 101138-101138
Open Access | Times Cited: 19
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, et al.
Annals of Hepatology (2023) Vol. 28, Iss. 6, pp. 101138-101138
Open Access | Times Cited: 19
Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogramming
Jawaher Alharthi, Ziyan Pan, Brian Gloss, et al.
Metabolism (2023) Vol. 144, pp. 155583-155583
Closed Access | Times Cited: 17
Jawaher Alharthi, Ziyan Pan, Brian Gloss, et al.
Metabolism (2023) Vol. 144, pp. 155583-155583
Closed Access | Times Cited: 17
The Intersection of Genetic Factors, Aberrant Nutrient Metabolism and Oxidative Stress in the Progression of Cardiometabolic Disease
Andrew Butcko, Ashley K. Putman, Emilio P. Mottillo
Antioxidants (2024) Vol. 13, Iss. 1, pp. 87-87
Open Access | Times Cited: 5
Andrew Butcko, Ashley K. Putman, Emilio P. Mottillo
Antioxidants (2024) Vol. 13, Iss. 1, pp. 87-87
Open Access | Times Cited: 5
Gut microbiota in MAFLD: therapeutic and diagnostic implications
Waleed Alghamdi, Mahmoud Mosli, Saleh A. Alqahtani
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access | Times Cited: 5
Waleed Alghamdi, Mahmoud Mosli, Saleh A. Alqahtani
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access | Times Cited: 5
Telomere length and mortality in lean MAFLD: the other face of metabolic adaptation
Mohammad Alarabi, Ziyan Pan, Manuel Romero‐Gómez, et al.
Hepatology International (2024) Vol. 18, Iss. 5, pp. 1448-1458
Closed Access | Times Cited: 5
Mohammad Alarabi, Ziyan Pan, Manuel Romero‐Gómez, et al.
Hepatology International (2024) Vol. 18, Iss. 5, pp. 1448-1458
Closed Access | Times Cited: 5
Transitioning from NAFLD to MAFLD and MASLD: the toxic relationship with alcohol consumption
Mübin Özercan, Ahmed Tawheed, Mohamed El‐Kassas
Exploration of Medicine (2025)
Open Access
Mübin Özercan, Ahmed Tawheed, Mohamed El‐Kassas
Exploration of Medicine (2025)
Open Access
Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction–Associated Steatotic Liver Diseases: A Pathway to Precision Medicine
Xiang Zhang, Kyong‐Mi Chang, Jun Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2025) Vol. 20, Iss. 1, pp. 375-403
Closed Access
Xiang Zhang, Kyong‐Mi Chang, Jun Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2025) Vol. 20, Iss. 1, pp. 375-403
Closed Access
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
Christopher D. Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access
Christopher D. Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access
Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application
Yang Chen, Rui Liang, Yong Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Yang Chen, Rui Liang, Yong Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Andrea Caddeo, Rocco Spagnuolo, Samantha Maurotti
Liver International (2023) Vol. 43, Iss. 11, pp. 2351-2364
Open Access | Times Cited: 9
Gut Microbes, Diet, and Genetics as Drivers of Metabolic Liver Disease: A Narrative Review Outlining Implications for Precision Medicine
Jake B. Hermanson, Samar A. Tolba, Evan A. Chrisler, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 133, pp. 109704-109704
Closed Access | Times Cited: 3
Jake B. Hermanson, Samar A. Tolba, Evan A. Chrisler, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 133, pp. 109704-109704
Closed Access | Times Cited: 3
Fibrosis score 4 index has an independent relationship with coronary artery diseases in patients with metabolic-associated fatty liver disease
Maryam Namakchian, Soghra Rabizadeh, Sara Seifouri, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Maryam Namakchian, Soghra Rabizadeh, Sara Seifouri, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Membrane-bound O-acyltransferase 7 (MBOAT7) shapes lysosomal lipid homeostasis and function to control alcohol-associated liver injury
Venkateshwari Varadharajan, Iyappan Ramachandiran, William J. Massey, et al.
eLife (2024) Vol. 12
Open Access | Times Cited: 2
Venkateshwari Varadharajan, Iyappan Ramachandiran, William J. Massey, et al.
eLife (2024) Vol. 12
Open Access | Times Cited: 2
Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation
Mary P. Moore, Xiaobo Wang, John P. Kennelly, et al.
Hepatology (2024)
Closed Access | Times Cited: 2
Mary P. Moore, Xiaobo Wang, John P. Kennelly, et al.
Hepatology (2024)
Closed Access | Times Cited: 2
MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight
Ziyan Pan, Maryam Al Khatry, Ming‐Lung Yu, et al.
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access | Times Cited: 2
Ziyan Pan, Maryam Al Khatry, Ming‐Lung Yu, et al.
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access | Times Cited: 2
The Pivotal Role of the Membrane-Bound O-Acyltransferase Domain Containing 7 in Non-Alcoholic Fatty Liver Disease
Preethi Chandrasekaran, Ralf Weiskirchen
Livers (2023) Vol. 4, Iss. 1, pp. 1-14
Open Access | Times Cited: 4
Preethi Chandrasekaran, Ralf Weiskirchen
Livers (2023) Vol. 4, Iss. 1, pp. 1-14
Open Access | Times Cited: 4
MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort
Spencer Goble, Joseph Akambase, Jhon Prieto, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 11, pp. 4212-4220
Open Access | Times Cited: 3
Spencer Goble, Joseph Akambase, Jhon Prieto, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 11, pp. 4212-4220
Open Access | Times Cited: 3
Membrane-bound O-acyltransferase 7 (MBOAT7) shapes lysosomal lipid homeostasis and function to control alcohol-associated liver injury
Venkateshwari Varadharajan, Iyappan Ramachandiran, William J. Massey, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 3
Venkateshwari Varadharajan, Iyappan Ramachandiran, William J. Massey, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 3
MBOAT7 expression is associated with disease progression in COVID-19 patients
Eman Radwan, Ahmed Abdelaziz, Manal Mandour, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access
Eman Radwan, Ahmed Abdelaziz, Manal Mandour, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access
Membrane Bound O-Acyltransferase 7 (MBOAT7) Shapes Lysosomal Lipid Homeostasis and Function to Control Alcohol-Associated Liver Injury
Venkateshwari Varadharajan, Iyappan Ramachandiran, William J. Massey, et al.
(2024)
Open Access
Venkateshwari Varadharajan, Iyappan Ramachandiran, William J. Massey, et al.
(2024)
Open Access
A Cell Specific Effect of MBOAT7 MAFLD-risk Variant on Immune Cells
Ziyan Pan, Jawaher Alharthi, Ali Bayoumi, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 4, pp. 148-148
Open Access
Ziyan Pan, Jawaher Alharthi, Ali Bayoumi, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 4, pp. 148-148
Open Access
A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact
Ziyan Pan, Wai‐Kay Seto, Chun‐Jen Liu, et al.
HepatoBiliary Surgery and Nutrition (2024) Vol. 13, Iss. 4, pp. 650-661
Open Access
Ziyan Pan, Wai‐Kay Seto, Chun‐Jen Liu, et al.
HepatoBiliary Surgery and Nutrition (2024) Vol. 13, Iss. 4, pp. 650-661
Open Access
Phospholipid Acyltransferases: Characterization and Involvement of the Enzymes in Metabolic and Cancer Diseases
Jan Korbecki, Mateusz Bosiacki, Maciej Pilarczyk, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2115-2115
Open Access
Jan Korbecki, Mateusz Bosiacki, Maciej Pilarczyk, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2115-2115
Open Access
